Sign in
Explore the registryTrack Intismeran autogene's trials

A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

Intismeran autogeneOngoingActive not recruitingPhase 3Open NCT05933577 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…